Cited by 129

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies

Kelliher, M., Fastbom, J., Cowburn, R.F., Bonkale, W., Ohm, T.G., Ravid, R., Sorrentino, V., O'Neill, C.·1999·Neuroscience

Abstract

Investigation of the integrity of the ryanodine receptor in Alzheimer's disease is important because it plays a critical role in the regulation of calcium release from the endoplasmic reticulum in brain, impairment of which is believed to contribute to the pathogenesis of Alzheimer's disease. The present study compared ryanodine receptor levels and their functional modulation in particulate fractions from control and Alzheimer's disease temporal cortex, occipital cortex and putamen. Relationships between ryanodine receptor changes and the progression of Alzheimer's disease pathology were determined by examining autoradiographic [3H]ryanodine binding in entorhinal cortex/anterior hippocampus sections from 22 cases that had been staged for neurofibrillary changes and beta-amyloid deposition. A significant (P < 0.02) 40% decrease in the Bmax for [3H]ryanodine binding and significantly higher IC50 values for both magnesium and Ruthenium Red inhibition of [3H]ryanodine binding were detected in Alzheimer's disease temporal cortex particulate fractions compared to controls. Immunoblot analyses showed Type 2 ryanodine receptor holoprotein levels to be decreased by 20% (P < 0.05) in these Alzheimer's disease cases compared to controls. No significant differences were detected in [3H]ryanodine binding comparing control and Alzheimer's disease occipital cortex or putamen samples. The autoradiography study detected increased [3H]ryanodine binding in the subiculum, CA2 and CA1 regions in…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(99)00042-1

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. Alcazar, 1997, Calcium mobilization by ryanodine promotes the phosphorylation of initiation factor 2α subunit and inhibits protein synthesis in cultured neurons, J. Neurochem., 69, 1703, 10.1046/j.1471-4159.1997.69041703.x · DOI
  2. Arendt, 1995, Increased expression and subcellular translocation of the mitogen-activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease, Neuroscience, 68, 5, 10.1016/0306-4522(95)00146-A · DOI
  3. Berridge, 1997, Elementary and global aspects of calcium signalling, J. exp. Biol., 200, 315, 10.1242/jeb.200.2.315 · DOI
  4. Brandt, 1992, Mapping of the calpain proteolysis products of the junctional foot protein of the skeletal muscle triad junction, J. Membr. Biol., 127, 35, 10.1007/BF00232756 · DOI
  5. Breuer, 1992, Fast axonal transport is modulated by altering trans-axolemmal calcium flux, Cell Calcium, 13, 249, 10.1016/0143-4160(92)90013-I · DOI
  6. Brillantes, 1994, Stabilisation of calcium release channel (ryanodine receptor) function by FK506-binding protein, Cell, 77, 513, 10.1016/0092-8674(94)90214-3 · DOI
  7. Brooks, 1992, Bound and determined: a computer program for making buffers of defined ion concentrations, Analyt. Biochem., 201, 119, 10.1016/0003-2697(92)90183-8 · DOI
  8. Brun A. An overview of light and microscopic changes. (1983) In Alzheimer's Disease: The Standard Reference. (ed. Reisberg B.), pp. 37–47, Free Press, New York.
  9. Cameron, 1995, Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux, Cell, 83, 463, 10.1016/0092-8674(95)90124-8 · DOI
  10. Cavallaro, 1997, Late memory-related genes in the hippocampus revealed by RNA fingerprinting, Proc. natn. Acad. Sci. U.S.A., 94, 9669, 10.1073/pnas.94.18.9669 · DOI
  11. Chavis, 1996, Functional coupling between ryanodine receptors and L-type calcium channels in neurons, Nature, 382, 719, 10.1038/382719a0 · DOI
  12. Chu, 1990, Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel, Molec. Pharmac., 37, 735, 10.1016/S0026-895X(25)10918-8 · DOI
  13. Cook, 1996, Expression and analysis of presenilin 1 in a human neuronal system: localisation in cell bodies and dendrites, Proc. natn. Acad. Sci. U.S.A., 93, 9223, 10.1073/pnas.93.17.9223 · DOI
  14. Cook, 1997, Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nature Med., 3, 1021, 10.1038/nm0997-1021 · DOI
  15. Coronado, 1994, Structure and function of ryanodine receptors, Am. J. Physiol., 266, C1485, 10.1152/ajpcell.1994.266.6.C1485 · DOI
  16. Cowburn, 1992, Adenylyl cyclase activity in postmortem human brain: evidence for altered G protein mediation in Alzheimer's disease, J. Neurochem., 58, 1409, 10.1111/j.1471-4159.1992.tb11357.x · DOI
  17. Cowburn, 1996, Neurotransmitter receptor/G protein mediated signal transduction in Alzheimer's disease brain, Neurodegeneration, 5, 483, 10.1006/neur.1996.0067 · DOI
  18. Fiorillo, 1998, Glutamate mediates an inhibitory post-synaptic potential in dopamine neurons, Nature, 394, 78, 10.1038/27919 · DOI
  19. Flynn, 1995, Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease, J. Neurochem., 64, 1888, 10.1046/j.1471-4159.1995.64041888.x · DOI
  20. Furuichi, 1994, Multiple types of ryanodine receptor/Ca2+ release channels are differentially expressed in rabbit brain, J. Neurosci., 14, 4794, 10.1523/JNEUROSCI.14-08-04794.1994 · DOI
  21. Garlind, 1995, Diminished [3H]inositol (1,4,5)P3 but not [3H]inositol (1,3,4,5)P4 binding in Alzheimer's disease brain, Brain Res., 681, 160, 10.1016/0006-8993(95)00311-D · DOI
  22. Geary, 1985, Quantitative film autoradiography for tritium methodological considerations, Brain Res., 337, 99, 10.1016/0006-8993(85)91613-0 · DOI
  23. Ghosh, 1995, Calcium signalling in neurons: molecular mechanisms and cellular consequences, Science, 268, 239, 10.1126/science.7716515 · DOI
  24. Giannini, 1995, The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues, J. Cell Biol., 128, 893, 10.1083/jcb.128.5.893 · DOI
  25. Gong, 1994, Alzheimer's disease abnormally phosphorylated τ is dephosphorylated by protein phosphatase-2B (calcineurin), J. Neurochem., 62, 803, 10.1046/j.1471-4159.1994.62020803.x · DOI
  26. Gong, 1995, Phosphatase activity towards abnormally phosphorylayed τ: decrease in Alzheimer disease brain, J. Neurochem., 65, 732, 10.1046/j.1471-4159.1995.65020732.x · DOI
  27. Greenwood, 1995, Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease, Neuroscience, 69, 125, 10.1016/0306-4522(95)00220-D · DOI
  28. Grynspan, 1997, Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease, Brain Res., 763, 145, 10.1016/S0006-8993(97)00384-3 · DOI
  29. Guo, 1996, Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitises PC-12 cells to death induced by amyloid β-peptide, NeuroReport, 8, 379, 10.1097/00001756-199612200-00074 · DOI
  30. Guo, 1997, Alzheimer's presenilin mutation sensitises neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals, J. Neurosci., 17, 4212, 10.1523/JNEUROSCI.17-11-04212.1997 · DOI
  31. Hain, 1995, Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle, J. biol. Chem., 270, 2047, 10.1074/jbc.270.5.2074 · DOI
  32. Hardy, 1997, Amyloid, the presenilins and Alzheimer's disease, Trends Neurosci., 20, 154, 10.1016/S0166-2236(96)01030-2 · DOI · Paper page
  33. Hartmann, 1998, Distinct sites of intracellular production for Alzheimer's Aβ40/42 amyloid peptides, Nature Med., 3, 1016, 10.1038/nm0997-1016 · DOI
  34. Hutton, 1998, The presenilins and Alzheimer's disease, Human molec. Genet., 6, 1639, 10.1093/hmg/6.10.1639 · DOI
  35. Johnson, 1996, Tau protein in normal and Alzheimer's disease brain, Alzheimer's Dis. Rev., 1, 38
  36. Jolly-Tornetta, 1998, Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N), J. biol. Chem, 273, 14015, 10.1074/jbc.273.22.14015 · DOI
  37. Jope, 1997, Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain, Neurobiol. Aging, 18, 111, 10.1016/S0197-4580(96)00205-9 · DOI
  38. Kawai, 1989, Effects of ryanodine on spike after-hyperpolarisation in sympathetic neurones of the rat superior cervical ganglion, Pflügers Arch. Eur. J. Physiol., 413, 470, 10.1007/BF00594175 · DOI
  39. Kovacs, 1996, Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nature Med., 2, 224, 10.1038/nm0296-224 · DOI
  40. Kurumatani, 1998, Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology, Brain Res., 796, 209, 10.1016/S0006-8993(98)00347-3 · DOI
  41. Ladner, 1995, Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease, J. Neuropath. exp. Neurol., 54, 783, 10.1097/00005072-199511000-00005 · DOI
  42. Laemmli, 1970, Cleavage of structural proteins during assembly of the macrophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
  43. Lah, 1997, Light and electron microscopic localization of presenilin-1 in primate brain, J. Neurosci., 17, 1971, 10.1523/JNEUROSCI.17-06-01971.1997 · DOI · Paper page
  44. Lokuta, 1997, Modulation of cardiac ryanodine receptors by sorcin, J. biol. Chem., 272, 25333, 10.1074/jbc.272.40.25333 · DOI
  45. Makrill, 1997, Differential expression and regulation of ryanodine receptor and myo-inositol 1,4,5-trisphosphate receptor calcium release channels in mammalian tissues and cell lines, Biochem. J., 327, 251, 10.1042/bj3270251 · DOI
  46. Markwell, 1978, Modification of the standard Lowry procedure to simplify protein determination in membranes and lipoprotein samples, Analyt. Biochem., 87, 206, 10.1016/0003-2697(78)90586-9 · DOI
  47. Mattson, 1991, Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurones, Molec. chem. Neuropath., 15, 117, 10.1007/BF03159951 · DOI
  48. Mattson, 1998, Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease, J. Neurochem., 70, 1, 10.1046/j.1471-4159.1998.70010001.x · DOI
  49. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  50. McPherson, 1993, Characterization of the major brain isoform of the ryanodine receptor/Ca2+ release channel, J. biol. Chem., 268, 19785, 10.1016/S0021-9258(19)36582-2 · DOI
  51. Meissner, 1994, Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors, A. Rev. Physiol., 56, 485, 10.1146/annurev.ph.56.030194.002413 · DOI
  52. Meyers, 1998, Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels, J. biol. Chem., 273, 18930, 10.1074/jbc.273.30.18930 · DOI
  53. Michalak, 1988, Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle, Biochim. biophys. Acta., 939, 587, 10.1016/0005-2736(88)90106-X · DOI
  54. Mirra, 1991, The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment for Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 · DOI · Paper page
  55. Munson, 1980, LIGAND: a versatile computerized approach for characterization of ligand-binding systems, Analyt. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 · DOI
  56. Nishimura, 1990, Ryanodine facilitates calcium dependent release of transmitter at mouse neuromuscular junction, Br. J. Pharmac., 100, 114, 10.1111/j.1476-5381.1990.tb12061.x · DOI
  57. Nixon, 1994, Calcium activated neutral proteinase (calpain) system in aging and Alzheimer's disease, Ann. N.Y. Acad. Sci., 747, 77, 10.1111/j.1749-6632.1994.tb44402.x · DOI
  58. Ohm, 1989, A competition between silver-stain and immunocytochemistry, J. neural. Transm., 1, 111, 10.1007/BF02312273 · DOI
  59. Ohm, 1995, Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes, Neuroscience, 64, 209, 10.1016/0306-4522(95)90397-P · DOI
  60. Ohm, 1997, Decrease in adenylate cyclase activity antecedes neurofibrillary tangle formation, Neurobiol. Aging, 18, 275, 10.1016/S0197-4580(97)80307-7 · DOI
  61. O'Neill, 1991, Coupling of human brain cerebral cortical α2-adrenoreceptors to GTP-binding proteins in Alzheimer's disease, Brain Res., 563, 39, 10.1016/0006-8993(91)91512-Y · DOI
  62. O'Neill, 1994, Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain, Brain Res., 636, 193, 10.1016/0006-8993(94)91017-0 · DOI
  63. Padua, 1994, Ionic strength of calcium, adenine nucleotide, magnesium and caffeine actions on ryanodine receptors in rat brain, J. Neurochem., 62, 2340, 10.1046/j.1471-4159.1994.62062340.x · DOI
  64. Paschen, 1996, Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis, J. Neurochem., 67, 1735, 10.1046/j.1471-4159.1996.67041735.x · DOI
  65. Pearson, 1989, The neuroanatomy of Alzheimer's disease, Rev. Neurosci., 2, 101, 10.1515/REVNEURO.1989.2.2.101 · DOI
  66. Querfurth, 1997, Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells, J. Neurochem., 69, 1580, 10.1046/j.1471-4159.1997.69041580.x · DOI
  67. Rardon, 1990, Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Effects on the Ca2+ release channel, Circulation Res., 67, 84, 10.1161/01.RES.67.1.84 · DOI
  68. Reisberg, 1982, The global deterioration scale (GDS): an instrument for the assessment of the primary degenerative dementia, Am. J. Psychiat., 139, 1136, 10.1176/ajp.139.9.1136 · DOI
  69. Saito, 1993, Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration, Proc. natn. Acad. Sci. U.S.A., 90, 2628, 10.1073/pnas.90.7.2628 · DOI
  70. Sharp, 1993, Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain, J. Neurosci., 13, 3051, 10.1523/JNEUROSCI.13-07-03051.1993 · DOI
  71. Shimohama, 1998, Phospholipase C isoenzymes in the human brain and their changes in Alzheimer's disease, Neuroscience, 82, 999, 10.1016/S0306-4522(97)00342-4 · DOI
  72. Shoshan-Barmatz, 1994, Endogenous Ca2+ dependent cysteine-protease cleaves specifically the ryanodine receptor/Ca2+ release channel in skeletal muscle, J. Membr. Biol., 142, 281, 10.1007/BF00233435 · DOI
  73. Simpson, 1995, Neuronal calcium stores: activation and function, Trends Neurosci., 18, 299, 10.1016/0166-2236(95)93919-O · DOI
  74. Simpson, 1996, Agonist evoked Ca2+ mobilization from stores expressing inositol 1,4,5-trisphosphate receptors and ryanodine receptors in cerebellar granule neurones, J. Neurochem., 67, 364, 10.1046/j.1471-4159.1996.67010364.x · DOI
  75. Smith, 1993, Characterisation and distribution of inositol polyphosphate and ryanodine receptors in the rat brain, J. Neurochem., 60, 1605, 10.1111/j.1471-4159.1993.tb13382.x · DOI
  76. Stein, 1992, High affinity [3H]ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine, Brain Res., 58, 5349
  77. Timerman, 1996, Characterisation of an exchange reaction between soluble FKBP-12 and the FKBP ryanodine receptor complex, J. biol. Chem., 270, 2451
  78. Verkhratsky, 1996, Calcium-induced calcium release in neurones, Cell Calcium, 19, 1, 10.1016/S0143-4160(96)90009-3 · DOI
  79. Walter, 1996, The Alzheimer's disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum, Molec. Med., 2, 673, 10.1007/BF03401652 · DOI
  80. Younkin, 1995, Evidence that A beta 42 is the real culprit in Alzheimer's disease, Ann. Neurol., 37, 287, 10.1002/ana.410370303 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kelliher, M., Fastbom, J., Cowburn, R. F., Bonkale, W., Ohm, T. G., Ravid, R., Sorrentino, V., & O'Neill, C.
Venue
Neuroscience
Publisher
Elsevier BV
Published
1999-05
Volume
92
Issue
2
Pages
499-513
ISSN
0306-4522
Cited by
129
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review